The Impact of TORasemide oN hemodynAmic and Neurohormonal Stress, and carDiac remOdeling in Heart Failure

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT01942109

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01942109
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Poland (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01942109. Randomized; double masking; primary purpose treatment. Start 2013-09 (registry gives no type); primary completion 2017-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Impact of TORasemide oN hemodynAmic and Neurohormonal Stress, and carDiac remOdeling in Heart Failure
Acronym
TORNADO
Condition
Heart Failure
Intervention (Drug)
Furosemide
Intervention (Drug)
Torasemide
Lead sponsor
Medical University of Warsaw (class: other)

Record details

Record id
cardio:ct-nct01942109
Content hash
8173e6e8897224702bb2866d3e21c1b9b281aae24fdfc365cb576fb0bb492d3c